Compound Detail
CHEMBL127
MEROPENEM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12
Basic Information
| ChEMBL ID | CHEMBL127 |
| Name | MEROPENEM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | DMJNNHOOLUXYBV-PQTSNVLCSA-N |
| Therapeutic | ✓ Yes |
10
Targets
10
Activities
3
Assay Types
30
PK Parameters
20
Publications
14
Known Names
20
Indications
1
Mechanisms
Molecular Properties
383.5
MW (Da)
-0.31
ALogP
6
HBA
3
HBD
110.2
PSA (Ų)
0.56
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1996 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Bacterial penicillin-binding protein inhibitor | INHIBITOR | Bacterial penicillin-binding protein | ✓ | ✓ |
Indications
Bacteremia Bacterial Infections Infections Intraabdominal Infections Meningitis Meningitis Meningitis, Bacterial Urinary Tract Infections Enterobacteriaceae Infections Lung Diseases Mental Disorders Neonatal Sepsis Pneumonia Pneumonia, Bacterial Pneumonia, Ventilator-Associated Pyelonephritis Sepsis Shock, Septic Urinary Bladder Neoplasms Appendicitis
ATC Classification
J01DH02
meropenem
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIBACTERIALS FOR SYSTEMIC USE
Activity Summary
Kd 4 meas. best 6.07
EC50 3 meas. best 6.9
IC50 3 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Staphylococcus aureus CHEMBL352 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Escherichia coli CHEMBL354 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Pseudomonas aeruginosa CHEMBL348 | IC50 | 7.7 | 7.7 | 20.0 | 1 |
| Streptokinase A CHEMBL1293228 | EC50 | 6.9 | 6.9 | 127.0 | 1 |
| Streptococcus sp. 'group A' CHEMBL612389 | EC50 | 6.82 | 6.82 | 153.0 | 1 |
| OXA-48 CHEMBL1287604 | Kd | 6.07 | 6.07 | 850.0 | 1 |
| Streptococcus CHEMBL612313 | EC50 | 5.94 | 5.94 | 1154.0 | 1 |
| Metallo-beta-lactamase type 2 CHEMBL1667695 | Kd | 4.96 | 4.96 | 11000.0 | 1 |
| Beta-lactamase VIM-2 CHEMBL5798 | Kd | 4.92 | 4.92 | 12000.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 4.12 | 4.12 | 75000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 6383.33 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 6860.0 | ng.hr.mL-1 | Mus musculus |
| AUC | - | hr | Mus musculus |
| AUC | 3.29 | ug ml-1 | - |
| AUC | 2.0 | hr | - |
| AUC | 6383.33 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 6383.33 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3.29 | ug ml-1 | Mus musculus |
| AUC | 6383.33 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 11583.33 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 166500.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 129500.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 6383.33 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 54.2 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 54.16 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 54.16 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 52.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 7.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 3.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.0 | L/hr | Homo sapiens |
| CL | 2.4 | L/hr | Homo sapiens |
| CL | 3.5 | L/hr | Homo sapiens |
| CL | 47.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 3.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 4.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 7.0 | mL.min-1.kg-1 | Macaca |
| CL | 51.16 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 40602.92 | nM | Mus musculus |
| Cmax | 19819.02 | nM | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 228 |
| 19029333 | 10.1128/aac.00485-08 | Acinetobacter pittii | 92 |
| 20679510 | 10.1128/aac.00257-10 | Pseudomonas aeruginosa | 79 |
| 20308376 | 10.1128/aac.00033-10 | Acinetobacter baumannii | 75 |
| 20308376 | 10.1128/aac.00033-10 | Pseudomonas aeruginosa | 75 |
| 20308376 | 10.1128/aac.00033-10 | Escherichia coli | 75 |
| 20308376 | 10.1128/aac.00033-10 | Klebsiella pneumoniae | 75 |
| 19995927 | 10.1128/aac.01190-09 | Klebsiella pneumoniae | 66 |
| 19738025 | 10.1128/aac.00574-09 | Pseudomonas aeruginosa | 64 |
| 19307366 | 10.1128/aac.01531-08 | Streptococcus pneumoniae | 55 |
| 17967915 | 10.1128/aac.00689-07 | Acinetobacter baumannii | 52 |
| 17967915 | 10.1128/aac.00689-07 | Pseudomonas aeruginosa | 51 |
| - | 10.1039/C1MD00095K | Pseudomonas aeruginosa | 51 |
| 29336873 | 10.1016/j.bmcl.2018.01.006 | Escherichia coli | 45 |
| 18779357 | 10.1128/aac.00381-08 | Pseudomonas aeruginosa | 42 |
| 20308379 | 10.1128/aac.01525-09 | Pseudomonas aeruginosa | 41 |
| 19805565 | 10.1128/aac.01099-09 | Klebsiella pneumoniae | 40 |
| 18591275 | 10.1128/aac.01684-07 | Acinetobacter baumannii | 40 |
| 17283197 | 10.1128/aac.00752-06 | Klebsiella pneumoniae | 39 |
| 19188398 | 10.1128/aac.01172-08 | Pseudomonas aeruginosa | 38 |
Data from ChEMBL 36 via Core Engine